Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused tricyclic heterocyclic compounds as HIV integrase inhibitors

Fused tricyclic heterocyclic compounds as HIV integrase inhibitors

US Patent 9951079 · Granted Apr 24, 2018

Estimated economic value: $111,994,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PCSK9 antagonist compounds2025
PCSK9 antagonist compounds2024
Cyclic polypeptides for PCSK9 inhibition2024
Broad spectrum influenza virus vaccine2023
Cyclic polypeptides for PCSK9 inhibition2022
PCSK9 antagonist compounds2022
PCSK9 antagonist compounds2022
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2022
PCSK9 antagonists bicyclo-compounds2022
Therapeutic compounds and uses thereof2022
Therapeutic compounds and uses thereof2021
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetyla2021